DOCSLIB.ORG

Fucoxanthin /239

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fucoxanthin /239 SUPPLEMENT MONOGRAPHS FUCOXANTHIN /239 daily can cause borborygmi and bloating. Doses greater than subjects with pseudohypolactasia than in control lactose 50 grams daily can cause cramps and diarrhea. Some are digesters. Am J Clin Nutr. 1999; 69:973-979. more sensitive to FOS and may develop gastrointestinal symptoms at lower doses. Those with lactose intolerance have been reported to experience gastrointestinal symptoms at a dose of 25 grams. Fucoxanthin DOSAGE AND ADMINISTRATION DESCRIPTION FOS are available as nutritional supplements and in function- Fucoxanthin is a marine carotenoid and a member of the al foods. Dosing is variable and ranges from 4 to 10 grams carotenoid family of chemical substances. Fucoxanthin, like daily and sometimes higher. Those who use more than 10 other carotenoids, is a natural fat-soluble pigment (brown, in grams daily should split the dosage throughout the day. the case of fucoxanthin) and is found in algae, including LITERATURE heterokonts and seaweeds, and in diatoms (phytoplankton). Alles MS, de Roos NM, Bakx JC, et al. Consumption of Fucoxanthin is also found in the edible brown seaweeds fructo-oligosaccharides does not favorably affect blood glucose wakame (Undaria pinnatifida), hijiki (Hijikia fusiformis) and and serum lipid concentrations in patients with type 2 diabetes. kombu (Laminaria japonica), as well as in the marine algae Am J Clin Nutr. 1999; 69:64-69. Chrysophyceae, Prymneslophyceae, Bacillariophyceae, Pra- Bouhnik Y, Vahedi K, Achour L, et al. Short-chain fructo- sinophyceae and Phaeophyceae. Fucoxanthin and its metab- oligosaccharide administration dose-dependently increases fecal olites are also typically found in sea organisms that feed on bifidobacteria in healthy humans. J Nutr. 1999; 129:113-116. these carotenoids as conjugates. For example, fucoxanthin Buddington RK, Williams CH, Chen SC, Witherly SA. Dietary esters and fucoxanthinol esters are found in clams. supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Fucoxanthin functions in algae as a light-harvesting pigment. Clin Nutr. 1996; 63:709-716. It and chlorophyll are the two major light-harvesting Luo J, van Yperselle M, Rizkalla SW, et al. Chronic pigments in brown algae and diatoms. Fucoxanthin exists in consumption of short-chain fructo-oligasaccharides does not algae in the form of a fucoxanthin-chlorophyll alc protein affect basal hepatic glucose production or insulin resistance in complex, which is associated, in the case of brown algae and type 2 diabetics. J Nutr.2000; 130:1572-1577. diatoms, with photosystem II. The complex transfers light to Ohta A, Baba S, Takizawa T, Adachi T. Effects of fructo- chlorophyll a. The fucoxanthin protein complex shows oligasaccharides on the absorption of magnesium in the homology to the chlorophyll aIb binding polypeptides of magnesium-deficientrat model. J Nutr Sci Vitamino/ (Tokyo). higher plants. 1994; 40:171-180. Ohta A, Motohashi Y, Sakai K, et al. Dietary fructo- Fucoxanthin, as an antioxidant, protects algae against oxygen oligasaccharides increase calcium absorption and levels of toxicity. Its possible protective roles as an antioxidant, as mucosal calbindin-D9K in the large intestine of gastrectomized well as its possible anti-inflammatory and anticancer activi- rats. Scand J Gastroenterol. 1998; 33:1062-1068. ties, have become of interest to researchers in the past Ohta A, Ohtsuki M, Hosoro A, et al. Dietary fructo- decade. More recently, its possible activity as an anti-obesity oligosaccharidesprevent osteopenia after gastrectomy.J Nutr. agent has stimulated research on the carotenoid, mainly in 1998; 128:106-110. Japan. Oku T, Tokunaga T, Hosoya N. Nondigestibility of a new sweetener, "Neosugar," in the rat. J Nutr. 1984; 114:1574-1581. Fucoxanthin is chemically described as [(IS,3R)-3-hydroxy- Pierre F, Perrin P, Champ M, et al. Short-chain fructo- 4-[(3E,5E,7E,9E, lIE, 13E,15E)-18-[( IS,4S,6R)-4-hydroxy- oligosaccharides reduce the occurrence of colon tumors and 2,2,6-trimethyl-70xabicyclo[4.1.0]heptan-l-yl]-3,7, 12, 16- develop gut-associated lymphoid tissue in Min mice. Cancer tetramethyl-17-oxooctadeca-l ,3,5,7,9, 11,13, 15-octaenyli- Res. 1997; 57: 225-228. dene]-3,5, 5-trimethylcyclohexyl] acetate. It is also known Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev as3'-(Acetyloxy)-6',7' -didehydro-5,6-epoxy-5,5' ,6,6',7,8- Nutr. 1998; 18:117-143. hexahydro-3,5'-dihydroxy-8-oxo-beta,beta-carotene; Sahaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects (3'S,5'R,6' R)- 3'-acetoxy-5,6-epoxy-3,5'-dihydroxy-6', 7' -di- of a milk product, fermented by Lactobaccillus acidophilus and dehydro-5,6,7 ,8,5' ,6'-hexahydro- 13.I3-carotene-8-one; and with fructo-oligosaccharides added, on blood lipids in male (3S,3' S,5R,5' R,6S,6'R)- 3'-(aacetyloxy)-6',7' -didehydro-5,6- volunteers. Eur J Clin Nutr. 1998;52:436-440. epoxy-5,5' ,6,6',7 ,8-hexahydro-3,5'-dihydroxy-8-oxo-I3,I3- Teuri U, Vapaatalo H, Korpela R. Fructo-oligosaccharides and carotene. Its CAS registry number is 3351-86-8, its empirical lactulose cause more symptoms in-lactose maldigesters and formula is C42Hss06, and its molecular weight is 658.91. .. 240 I FUCOXANTHIN PDR FOR NUTRITIONAL SUPPLEMENTS Fucoxanthin's allenic group (=CH=C=CH-) and 5,6 monoe- and the transition of G) to the S phase. Fucoxanthin was poxide make fucoxanthin a unique chemical structure (see found to inhibit the phosphorylation of Rb. Further, the figure). Fucoxanthin is also classified as an epoxyxantho- kinase activity of cyclin D when joined with its partner phyll or epoxide-containing xanthophyll. Fucoxanthan is kinase CDK4 was suppressed by treatment with fucoxanthin. represented by the following chemical structure. Fucoxanthin also induced activity of the ubiquitin-protea- some pathway leading to degradation of cyclin D and suppressed cyclin D mRNA. Thus, it appears that fucoxan- thin caused the suppression of cyclin D via promotion of proteasomal degradation and repression of cyclin D, leading to cell cycle arrest. Incidentally, apoptosis was not observed in this case Fucoxanthin Fucoxanthin reduced the viability of the human colon Fucoxanthinol is the deacetylated metabolite of fucoxanthin. adenocarcinoma WiDr cell line accompanied by the induc- tion of cell cycle arrest at the GOGIphase of the cycle. In this ACTIONS AND PHARMACOLOGY ACTIONS case, apoptosis of the cells was also reported. In order to Fucoxanthin has antioxidant actIVIty and may have anti- understand the possible mechanism of fucoxanthin's action, cancer, anti-inflammatory and antiobesity activities. a number of factors that regulate the cell cycle were investigated, including the cyclins, the cyclin-dependent MECHANISM OF ACTION kinases (CDKs), the retinoblastoma protein Rb and p21, a Antioxidant activity: Fucoxanthin has demonstrated radical key protein in cell cycle regulation. It was p2l that appeared scavenging and singlet oxygen quenching activities. The to be affected by fucoxanthin. When p2l binds to the CDKs, quenching activity of fucoxanthin against the organic radi- it inhibits their activity. It appeared that fucoxanthin induced cals 1,I-diphenyl-2-picrylhydrazyl (DPPH, a stable free cell-cycle arrest at the GOGIphase in human cancer cells via radical), 12-doxylstearic acid (12DS), and the radical adduct upregulation of the activity of p21. of nitrobenzene with linoleic acid (NB-L) was studied using electron spin resonance (ESR). In the presence of fucoxan- Fucoxanthin was reported to reduce the viability of human thin, the ESR signals for the DPPH, 12DS and NB-L radicals prostate cancer cells via the induction of apoptosis. Apopto- were significantly reduced. Fucoxanthin also has sis induction was characterized by DNA fragmentation, an 2,2'-azinobis(3 -ethyIbenzothiazoline-6-sulfonic acid) increased percentage of hypodiploid cells and cleavages of (ATBS) radical, hydroxyl radical, superoxide anion and procaspase-3 and PARP (poly(ADP-ribose) polymerase. singlet oxygen scavenging activity. Expression of Bax and Bcl-2 proteins, but not Bcl-XL proteins, was reduced. The activation of caspase-3 by Anticancer activity: Fucoxanthin has demonstrated a number fucoxanthin was thought to be the major activity in the of anticancer activities via different mechanisms. induction of apoptosis. Fucoxanthin was found to inhibit the growth of human Fucoxanthin was found to induce apoptosis III human hepatic HepG2 carcinoma cells. In 2007, cancer of the liver promyelocytic leukemia cells. Apoptosis in these cells was was the fourth most common cause of death from cancer. associated with loss of mitochondrial membrane potential, Most of the cases of hepatocellular cancer can be found in but not with an increase in reactive oxygen species. undeveloped countries. Fucoxanthin was shown to reduce Fucoxanthin treatment caused cleavages of procapsase-3 and the viability of HepG2 cells accompanied by the induction of poly (ADP-ribose) polymerase, without any effect on the cell cycle arrest during the GaG) phase of the cell cycle. The protein level of Bcl-2, Bcl-XL or Bax. It was concluded that cell cycle is the series of events that takes place in a cell the fucoxanthin induction of apoptosis was likely due to leading to its replication. The cell cycle consists of four mitochondrial membrane permeabilization and caspase-3 distinct phases Gj, S, G2 and the M phase, where the cell activation. divides forming two new cells. Go is the postmitotic phase prior to G I. Two key classes of regulatory molecules- Anti-inflammatory activity: Endotoxin-induced uveitis (EIU) cyclins and cyclin-dependent kinases (CDKs)-acting in (induced by lipopolysaccharide [LPS]) is an acute, anterior partnership, determine a cell's progress through the cell segment intraocular inflammation (uveitis). Fucoxanthin was cycle. The retinoblastoma protein Rb, a tumor suppressor studied to see how it affected LPS-induced inflammation in protein, prevents excessive growth by inhibiting the cell vitro in a mouse macrophage cell line and in vivo in male cycle when Rb is hypophosphorylated.
Load more

Recommended publications
  • Carotene in Obesity Research: Technical Considerations and Current Status of the Field
    nutrients Review β-carotene in Obesity Research: Technical Considerations and Current Status of the Field Johana Coronel 1, Ivan Pinos 2 and Jaume Amengual 1,2,* 1 Department of Food Sciences and Human Nutrition, University of Illinois Urbana Champaign, Urbana, IL 61801, USA; [email protected] 2 Division of Nutritional Sciences, University of Illinois Urbana Champaign, Urbana, IL 61801, USA; [email protected] * Correspondence: [email protected] Received: 16 February 2019; Accepted: 6 April 2019; Published: 13 April 2019 Abstract: Over the past decades, obesity has become a rising health problem as the accessibility to high calorie, low nutritional value food has increased. Research shows that some bioactive components in fruits and vegetables, such as carotenoids, could contribute to the prevention and treatment of obesity. Some of these carotenoids are responsible for vitamin A production, a hormone-like vitamin with pleiotropic effects in mammals. Among these effects, vitamin A is a potent regulator of adipose tissue development, and is therefore important for obesity. This review focuses on the role of the provitamin A carotenoid β-carotene in human health, emphasizing the mechanisms by which this compound and its derivatives regulate adipocyte biology. It also discusses the physiological relevance of carotenoid accumulation, the implication of the carotenoid-cleaving enzymes, and the technical difficulties and considerations researchers must take when working with these bioactive molecules. Thanks to the broad spectrum of functions carotenoids have in modern nutrition and health, it is necessary to understand their benefits regarding to metabolic diseases such as obesity in order to evaluate their applicability to the medical and pharmaceutical fields.
    [Show full text]
  • Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: a Promising Bioactive Compound for Cancer Therapy
    International Journal of Molecular Sciences Review Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy Sarah Méresse 1,2,3, Mostefa Fodil 1 , Fabrice Fleury 2 and Benoît Chénais 1,* 1 EA 2160 Mer Molécules Santé, Le Mans Université, F-72085 Le Mans, France; [email protected] (S.M.); [email protected] (M.F.) 2 UMR 6286 CNRS Unité Fonctionnalité et Ingénierie des Protéines, Université de Nantes, F-44000 Nantes, France; [email protected] 3 UMR 7355 CNRS Immunologie et Neurogénétique Expérimentales et Moléculaires, F-45071 Orléans, France * Correspondence: [email protected]; Tel.: +33-243-833-251 Received: 23 October 2020; Accepted: 2 December 2020; Published: 4 December 2020 Abstract: Fucoxanthin is a well-known carotenoid of the xanthophyll family, mainly produced by marine organisms such as the macroalgae of the fucus genus or microalgae such as Phaeodactylum tricornutum. Fucoxanthin has antioxidant and anti-inflammatory properties but also several anticancer effects. Fucoxanthin induces cell growth arrest, apoptosis, and/or autophagy in several cancer cell lines as well as in animal models of cancer. Fucoxanthin treatment leads to the inhibition of metastasis-related migration, invasion, epithelial–mesenchymal transition, and angiogenesis. Fucoxanthin also affects the DNA repair pathways, which could be involved in the resistance phenotype of tumor cells. Moreover, combined treatments of fucoxanthin, or its metabolite fucoxanthinol, with usual anticancer treatments can support conventional therapeutic strategies by reducing drug resistance. This review focuses on the current knowledge of fucoxanthin with its potential anticancer properties, showing that fucoxanthin could be a promising compound for cancer therapy by acting on most of the classical hallmarks of tumor cells.
    [Show full text]
  • Biologically Active Compounds in Seaweed Extracts Useful in Animal Diet
    20 The Open Conference Proceedings Journal, 2012, 3, (Suppl 1-M4) 20-28 Open Access Biologically Active Compounds in Seaweed Extracts - the Prospects for the Application Katarzyna Chojnacka*, Agnieszka Saeid, Zuzanna Witkowska and Łukasz Tuhy Institute of Inorganic Technology and Mineral Fertilizers, Wroclaw University of Technology ul. Smoluchowskiego 25, 50-372 Wroclaw, Poland Abstract: The paper covers the latest developments in research on the utilitarian properties of algal extracts. Their appli- cation as the components of pharmaceuticals, feeds for animals and fertilizers was discussed. The classes of various bio- logically active compounds were characterized in terms of their role and the mechanism of action in an organism of hu- man, animal and plant. Recently, many papers have been published which discuss the methods of manufacture and the composition of algal ex- tracts. The general conclusion is that the composition of extracts strongly depends on the raw material (geographical loca- tion of harvested algae and algal species) as well as on the extraction method. The biologically active compounds which are transferred from the biomass of algae to the liquid phase include polysaccharides, proteins, polyunsaturated fatty ac- ids, pigments, polyphenols, minerals, plant growth hormones and other. They have well documented beneficial effect on humans, animals and plants, mainly by protection of an organism from biotic and abiotic stress (antibacterial activity, scavenging of free radicals, host defense activity etc.) and can be valuable components of pharmaceuticals, feed additives and fertilizers. Keywords: Algal extracts, feed additives, fertilizers, pharmaceuticals, biologically active compounds. 1. INTRODUCTION was paid to biologically active compounds, useful as the components of pharmaceuticals, feeds and fertilizers.
    [Show full text]
  • A Review on Biosynthesis, Health Benefits and Extraction Methods of Fucoxanthin, Particular Marine Carotenoids in Algae
    Journal of Medicinal Plants A Review on Biosynthesis, Health Benefits and Extraction Methods of Fucoxanthin, Particular Marine Carotenoids in Algae Irvani N (M.Sc.)1, Hajiaghaee R (Ph.D.)2, Zarekarizi A.R (M.Sc.)2* 1- Faculty of Biological Science and Technology, Shahid Beheshti University, Tehran, Iran 2- Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran * Corresponding author: Institute of Medicinal Plants, ACECR, Karaj, Iran P.O.BOX (Mehr Vila): 31375-369 Tel: +98 - 26 – 34764010-18, Fax: +98 – 26- 34764021 E-mail: [email protected] Received: 28 June 2017 Accepted: 18 July 2018 Abstract Fucoxanthin, an allenic carotenoid, is abundant in macro and microalgae as a component of the light-harvesting complex for photosynthesis and photo protection. This carotenoid has shown important pharmaceutical bioactivity, exerting antioxidant, anti-cancer, anti-diabetic, anti- obesity, anti-photoaging, anti-angiogenic, and anti-metastatic effects on a variety of biological models. This carotenoid has been proven to be safe for animal consumption, opening up the opportunity of using this bioactive compound in the treatment of different pathologies. In this paper, an updated account of the research progress in biosynthetic pathway and health benefits of fucoxanthin is presented. Meanwhile, a review on the various methods of extraction of fucoxanthin in macro and microalgae is also revisited. According to these studies providing important background knowledge, fucoxanthin can be utilized into drugs and nutritional products. Keywords: Fucoxanthin, Carotenoids, Biosynthesis pathway, Extraction methods 6 Volume 17, No. 67, Summer 2018 … A Review on Biosynthesis Introduction million species [5]. Microalgae are important Consumer awareness of the importance of a primary producers in marine environments and healthy diet, protection of the environment, play a significant role in supporting aquatic resource sustainability and using all natural animals [6].
    [Show full text]
  • Chemical Cleavage of Fucoxanthin from Undaria Pinnatifida And
    Food Chemistry 211 (2016) 365–373 Contents lists available at ScienceDirect Food Chemistry journal homepage: www.elsevier.com/locate/foodchem Chemical cleavage of fucoxanthin from Undaria pinnatifida and formation of apo-fucoxanthinones and apo-fucoxanthinals identified using LC-DAD-APCI-MS/MS ⇑ Junxiang Zhu a, Xiaowen Sun a, Xiaoli Chen a, Shuhui Wang b, Dongfeng Wang a, a College of Food Science and Engineering, Ocean University of China, Qingdao 266003, People’s Republic of China b Qingdao Municipal Center for Disease Control & Prevention, Qingdao 266033, People’s Republic of China article info abstract Article history: As the most abundant carotenoid in nature, fucoxanthin is susceptible to oxidation under some condi- Received 11 September 2015 tions, forming cleavage products that possibly exhibit both positive and negative health effects in vitro Received in revised form 5 May 2016 and in vivo. Thus, to produce relatively high amounts of cleavage products, chemical oxidation of fucox- Accepted 11 May 2016 anthin was performed. Kinetic models for oxidation were probed and reaction products were identified. Available online 11 May 2016 The results indicated that both potassium permanganate (KMnO4) and hypochlorous acid/hypochlorite (HClO/ClOÀ) treatment fitted a first-order kinetic model, while oxidation promoted by hydroxyl radical Chemical compounds studied in this article: Å (OH ) followed second-order kinetics. With the help of liquid chromatography–tandem mass spectrom- Fucoxanthin (PubChem CID: 5281239) etry, a total of 14 apo-fucoxanthins were detected as predominant cleavage products, with structural Keywords: and geometric isomers identified among them. Three apo-fucoxanthinones and eleven apo- Fucoxanthin fucoxanthinals, of which five were cis-apo-fucoxanthinals, were detected upon oxidation by the three À Å Apo-fucoxanthins oxidizing agents (KMnO4, HClO/ClO , and OH ).
    [Show full text]
  • Photochemical Degradation of Antioxidants: Kinetics and Molecular End Products
    Photochemical degradation of antioxidants: kinetics and molecular end products Sofia Semitsoglou Tsiapou 2020 Americas Conference IUVA [email protected] 03/11/2020 Global carbon cycle and turnover of DOC 750 Atmospheric CO2 Surface Dissolved Inorganic C 610 1,020 Dissolved Terrestrial Organic Biosphere Carbon 662 Deep Dissolved 38,100 Inorganic C Gt C (1015 gC) Global carbon cycle and turnover of DOC DOC (mM) Stephens & Aluwihare ( unpublished) Buchan et al. 2014, Nature Reviews Microbiology Problem definition Enzymatic processes Bacteria Labile Recalcitrant Fungi Light Corganic Algae Corganic Radicals Carotenoids (∙OH, ROO∙) ➢ LC-MS ➢ GC-MS H2O-soluble products As Biomarkers for ➢ GC-IRMS Corg sources, fate and reactivity??? Hypotheses 1. Carotenoids in fungi neutralize free radicals and counteract oxidative stress and in marine environments are thought to serve as precursors for recalcitrant DOC 2. Carotenoid oxidation products can accumulate and their production and release can represent an important flux of recalcitrant DOC 3. Biological sources and diagenetic pathways of carotenoids are encoded into the fine-structure as well as isotopic composition of the degradation products FUNgal experiments Strains Culture cultivation - Unidentified - Potato Dextrose broth medium - Aspergillus candidus - Incubated 7 days - Aspergillus flavus - Aerobic conditions - Aspergillus terreus - Under natural light (28℃ ) - Penicillium sp. Biomass and Media Lyophilization extracts Bligh and Dyer method (for lipids analysis) FUNgal experiments a) ABTS assay: antioxidant activity Biomass and Media extracts b) LC-MS : CAR-like compounds c) Photo-oxidation of selected Biomass carotenoids extracts ABTS assay: fungal antioxidant activity Trolox Equivalent Antioxidant Capacity (TEAC) 400 350 300 250 200 Medium 150 Biomass extracted] 100 50 0 TEAC [µmol of Trolox/mg of biomass of of[µmol Trolox/mg TEAC Unidentified Aspergillus Aspergillus Aspergillus Penicillium candidus flavus terreus sp.
    [Show full text]
  • Crocin Suppresses Multidrug Resistance in MRP Overexpressing
    Mahdizadeh et al. DARU Journal of Pharmaceutical Sciences (2016) 24:17 DOI 10.1186/s40199-016-0155-8 RESEARCH ARTICLE Open Access Crocin suppresses multidrug resistance in MRP overexpressing ovarian cancer cell line Shadi Mahdizadeh1, Gholamreza Karimi2, Javad Behravan3,4, Sepideh Arabzadeh3, Hermann Lage5 and Fatemeh Kalalinia3,6* Abstract Background: Crocin, one of the main constituents of saffron extract, has numerous biological effects such as anti-cancer effects. Multidrug resistance-associated proteins 1 and 2 (MRP1 and MRP2) are important elements in the failure of cancer chemotherapy. In this study we aimed to evaluate the effects of crocin on MRP1 and MRP2 expression and function in human ovarian cancer cell line A2780 and its cisplatin-resistant derivative A2780/RCIS cells. Methods: The cytotoxicity of crocin was assessed by the MTT assay. The effects of crocin on the MRP1 and MRP2 mRNA expression and function were assessed by real-time RT-PCR and MTT assays, respectively. Results: Our study indicated that crocin reduced cell proliferation in a dose-dependent manner in which the reduction in proliferation rate was more noticeable in the A2780 cell line compared to A2780/RCIS. Crocin reduced MRP1 and MRP2 gene expression at the mRNA level in A2780/RCIS cells. It increased doxorubicin cytotoxicity on the resistant A2780/RCIS cells in comparison with the drug-sensitive A2780 cells. Conclusion: Totally, these results indicated that crocin could suppress drug resistance via down regulation of MRP transporters in the human ovarian cancer resistant cell line. Keywords: Crocin, Multidrug resistance, MRP1, MRP2, A2780, A2780/RCIS Background (ABC family) [4, 5].
    [Show full text]
  • 610-616 Research Article Extraction, Partially Purification
    Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(3):610-616 ISSN : 0975-7384 Research Article CODEN(USA) : JCPRC5 Extraction, partially purification and study on antioxidant property of fucoxanthin from Sargassum cinereum J. Agardh S. Sivasankara Narayani*1, S. Saravanan 1, S. Bharathiaraja 1 and S. Mahendran 2 1Centre of Advanced Study in Marine Biology, Faculty of Marine Sciences, Annamalai University, Parangipettai– 608 502, Tamil Nadu, India 2Department of Microbiology, Ayya Nadar Janaki Ammal College, Sivakasi -626124, Tamil Nadu, India _____________________________________________________________________________________________ ABSTRACT Fucoxanthin is a Xanthophyll. It is found as an accessory pigment in the chloroplasts of brown algae, Sargassum cinereum. The crude pigment was initially screened through TLC and then fucoxanthin was separated and partially purified using silica column chromatography (230 – 400 mesh). The yield of fucoxanthin from Sargassum cinereum was 2.0225mg/g of sample. Fucoxanthin was found to be present in Sargassum cinereum extract, which was detected using UV vis spectrophotometer at 422.90nm and identified using FT-IR, HPLC and GC-MS. The fucoxanthin was later checked with free radicals for its antioxidant property . 60µg/ml of pigment showed 50% of scavenging activity of free radicals. Keywords : Fucoxanthin, Brown seaweed, Antioxidant property, Silica gel Chromatography _____________________________________________________________________________________________ INTRODUCTION Seaweeds are excellent sources of bioactive compounds such as polyphenols, carotenoids and polysaccharides [6, 10, 17, 21]. These bioactive compounds can be applied in functional food, pharmaceuticals and cosmetic products as they bring health benefits to consumers [12, 14, 21]. Sargassum sp is brown seaweed . The major pigment of brown seaweeds is fucoxanthin, which is one of the most abundant carotenoids in nature (10% estimated total production of carotenoids) [12].
    [Show full text]
  • Review Article Recent Advances in Studies on the Therapeutic Potential of Dietary Carotenoids in Neurodegenerative Diseases
    Hindawi Oxidative Medicine and Cellular Longevity Volume 2018, Article ID 4120458, 13 pages https://doi.org/10.1155/2018/4120458 Review Article Recent Advances in Studies on the Therapeutic Potential of Dietary Carotenoids in Neurodegenerative Diseases 1 1 2,3 4 Kyoung Sang Cho , Myeongcheol Shin , Sunhong Kim , and Sung Bae Lee 1Department of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea 2Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea 3Department of Bioscience, University of Science and Technology, Daejeon 34113, Republic of Korea 4Department of Brain and Cognitive Sciences, DGIST, Daegu 42988, Republic of Korea Correspondence should be addressed to Sunhong Kim; [email protected] and Sung Bae Lee; [email protected] Received 22 November 2017; Revised 22 February 2018; Accepted 13 March 2018; Published 16 April 2018 Academic Editor: Julio B. Daleprane Copyright © 2018 Kyoung Sang Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Carotenoids, symmetrical tetraterpenes with a linear C40 hydrocarbon backbone, are natural pigment molecules produced by plants, algae, and fungi. Carotenoids have important functions in the organisms (including animals) that obtain them from food. Due to their characteristic structure, carotenoids have bioactive properties, such as antioxidant, anti-inflammatory, and autophagy-modulatory activities. Given the protective function of carotenoids, their levels in the human body have been significantly associated with the treatment and prevention of various diseases, including neurodegenerative diseases.
    [Show full text]
  • Carotenoids Database: Structures, Chemical Fingerprints and Distribution Among Organisms Junko Yabuzaki*
    Database, 2017, 1–11 doi: 10.1093/database/bax004 Original article Original article Carotenoids Database: structures, chemical fingerprints and distribution among organisms Junko Yabuzaki* Center for Information Biology, National Institute of Genetics, Yata 1111, Mishima, Shizuoka 411-8540, Japan *Corresponding author: Tel: þ81 774 23 2680; Fax: þ81 774 23 2680; Email: [email protected][AQ] Present address: Junko Yabuzaki, 1 34-9, Takekura, Mishima, Shizuoka 411-0807, Japan. Citation details: Yabuzaki,J. Carotenoids Database: structures, chemical fingerprints and distribution among organisms (2017) Vol. 2017: article ID bax004; doi:10.1093/database/bax004 Received 13 April 2016; Revised 14 January 2017; Accepted 16 January 2017 Abstract To promote understanding of how organisms are related via carotenoids, either evolu- tionarily or symbiotically, or in food chains through natural histories, we built the Carotenoids Database. This provides chemical information on 1117 natural carotenoids with 683 source organisms. For extracting organisms closely related through the biosyn- thesis of carotenoids, we offer a new similarity search system ‘Search similar caroten- oids’ using our original chemical fingerprint ‘Carotenoid DB Chemical Fingerprints’. These Carotenoid DB Chemical Fingerprints describe the chemical substructure and the modification details based upon International Union of Pure and Applied Chemistry (IUPAC) semi-systematic names of the carotenoids. The fingerprints also allow (i) easier prediction of six biological functions of carotenoids: provitamin A, membrane stabilizers, odorous substances, allelochemicals, antiproliferative activity and reverse MDR activity against cancer cells, (ii) easier classification of carotenoid structures, (iii) partial and exact structure searching and (iv) easier extraction of structural isomers and stereoisomers. We believe this to be the first attempt to establish fingerprints using the IUPAC semi- systematic names.
    [Show full text]
  • A Rapid Method for the Determination of Fucoxanthin in Diatom
    marine drugs Article A Rapid Method for the Determination of Fucoxanthin in Diatom Li-Juan Wang 1,2, Yong Fan 2,*, Ronald L. Parsons 3, Guang-Rong Hu 2, Pei-Yu Zhang 1,* and Fu-Li Li 2 ID 1 College of Environmental Science and Engineering, Qingdao University, Qingdao 266071, China; [email protected] 2 Key Laboratory of Biofuels, Shandong Provincial Key Laboratory of Synthetic Biology, Qingdao Engineering Laboratory of Single Cell Oil, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266101, China; [email protected] (G.-R.H.); lifl@qibebt.ac.cn (F.-L.L.) 3 Solix Algredients Inc., 120 Commerce Dr., Ste 4, Fort Collins, CO 80524, USA; [email protected] * Correspondence: [email protected] (Y.F.); [email protected] (P.-Y.Z.); Tel.: +86-0532-80662656 (Y.F.); +86-0532-83780155 (P.-Y.Z.) Received: 4 December 2017; Accepted: 6 January 2018; Published: 22 January 2018 Abstract: Fucoxanthin is a natural pigment found in microalgae, especially diatoms and Chrysophyta. Recently, it has been shown to have anti-inflammatory, anti-tumor, and anti-obesityactivity in humans. Phaeodactylum tricornutum is a diatom with high economic potential due to its high content of fucoxanthin and eicosapentaenoic acid. In order to improve fucoxanthin production, physical and chemical mutagenesis could be applied to generate mutants. An accurate and rapid method to assess the fucoxanthin content is a prerequisite for a high-throughput screen of mutants. In this work, the content of fucoxanthin in P. tricornutum was determined using spectrophotometry instead of high performance liquid chromatography (HPLC).
    [Show full text]
  • Lessons Learned
    Prevention and Reversal of Chronic Disease Copyright © 2019 RN Kostoff PREVENTION AND REVERSAL OF CHRONIC DISEASE: LESSONS LEARNED By Ronald N. Kostoff, Ph.D., School of Public Policy, Georgia Institute of Technology 13500 Tallyrand Way, Gainesville, VA, 20155 [email protected] KEYWORDS Chronic disease prevention; chronic disease reversal; chronic kidney disease; Alzheimer’s Disease; peripheral neuropathy; peripheral arterial disease; contributing factors; treatments; biomarkers; literature-based discovery; text mining ABSTRACT For a decade, our research group has been developing protocols to prevent and reverse chronic diseases. The present monograph outlines the lessons we have learned from both conducting the studies and identifying common patterns in the results. The main product of our studies is a five-step treatment protocol to reverse any chronic disease, based on the following systemic medical principle: at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective. Implementation of the five-step treatment protocol is as follows: FIVE-STEP TREATMENT PROTOCOL TO REVERSE ANY CHRONIC DISEASE Step 1: Obtain a detailed medical and habit/exposure history from the patient. Step 2: Administer written and clinical performance and behavioral tests to assess the severity of symptoms and performance measures. Step 3: Administer laboratory tests (blood, urine, imaging, etc) Step 4: Eliminate ongoing contributing factors to the chronic disease Step 5: Implement treatments for the chronic disease This individually-tailored chronic disease treatment protocol can be implemented with the data available in the biomedical literature now. It is general and applicable to any chronic disease that has an associated substantial research literature (with the possible exceptions of individuals with strong genetic predispositions to the disease in question or who have suffered irreversible damage from the disease).
    [Show full text]